LikeADaVinci
Bluelighter
- Joined
- Dec 31, 2023
- Messages
- 28
So, if you look at the bseline DA efflux in the nucleus accumbens and then compare the DA (dopamine) levels after peak plasma of methadone is achieved, you will notice an actual DECREASE in synaptic DA by about 10% …
Now, the orthodox school of thought as relating to activation of the mu receptor is that, there is a downstream inhibition of GABA inter neurons in the ventral tagmental area, thereby disinhibiting the release of dopamine to the NAC shell — this is thought to be inherent to activation of the mu receptor itself
Yet, methadone causes a net 10% DECREASE in DA in the NAC shell, and fentanyl causes only a 250% increase in DA efflux in the NAC shell, whereas traditional morphinon opioids such as heroin cause a 350% increase in DA efflux at the NAC shell at peak.
What gives?
Obviously the mu receptor is more complicated than we think, with simple agonist / antagonist / partial agonist activity … i postulate that the mu receptor has several (at least three) isoforms whereby the molecular docking in inherent to the: A) analgesic effects B) Respiratory Effects C) gastrointestinal effects D) effect on VTA GABA inter neurons which disinhibit Dopamine release to the NAC.
I think that the shape of the molecule is what causes activation of the different isoforms of the receptor to cause either of the four (or more?) functions to occur …
The reason I am wondering this, is that the analgesic activity seems to be inherently interrelated to addiction potential, rather than the downstream inhibition of GABA and increase in NAC dopamine levels, and so: maybe it is possible to model, chemically, the “missing” part of the methadone molecule as compared to morphine, to elucidate a compound which ONLY disinhibits dopamine without affecting the mu receptor isoform inherent to analgesic activity and hence: derive a molecule which causes the pleasure of inhibiting GABA in the ventral tagmental area, while not being so severely addictive (esp. physically addictive) as all (currently known) mu-receptor agonists are
P.S. interestingly, I have read in the literature that with traditional morphinons, a phenethyl substitution at the tertiary amine in E-ring (replacing n-methyl) produces a compound with DRASTICALLY LOWER addiction potential, while conferring 8-14 fold increases in potency,
And
14-methoxy moities added to traditional morphinons create a molecule which virtually lacks all respiratory depression! (While as well conferring a 500 fold increase in potency and 100 fold tighter binding affinity to the mu receptor)
I can dig up the references for the above claims if you need to see them
— there is a lot yet to be discovered about the Mu receptor, it seems !!! —
LikeADaVinci
Now, the orthodox school of thought as relating to activation of the mu receptor is that, there is a downstream inhibition of GABA inter neurons in the ventral tagmental area, thereby disinhibiting the release of dopamine to the NAC shell — this is thought to be inherent to activation of the mu receptor itself
Yet, methadone causes a net 10% DECREASE in DA in the NAC shell, and fentanyl causes only a 250% increase in DA efflux in the NAC shell, whereas traditional morphinon opioids such as heroin cause a 350% increase in DA efflux at the NAC shell at peak.
What gives?
Obviously the mu receptor is more complicated than we think, with simple agonist / antagonist / partial agonist activity … i postulate that the mu receptor has several (at least three) isoforms whereby the molecular docking in inherent to the: A) analgesic effects B) Respiratory Effects C) gastrointestinal effects D) effect on VTA GABA inter neurons which disinhibit Dopamine release to the NAC.
I think that the shape of the molecule is what causes activation of the different isoforms of the receptor to cause either of the four (or more?) functions to occur …
The reason I am wondering this, is that the analgesic activity seems to be inherently interrelated to addiction potential, rather than the downstream inhibition of GABA and increase in NAC dopamine levels, and so: maybe it is possible to model, chemically, the “missing” part of the methadone molecule as compared to morphine, to elucidate a compound which ONLY disinhibits dopamine without affecting the mu receptor isoform inherent to analgesic activity and hence: derive a molecule which causes the pleasure of inhibiting GABA in the ventral tagmental area, while not being so severely addictive (esp. physically addictive) as all (currently known) mu-receptor agonists are
P.S. interestingly, I have read in the literature that with traditional morphinons, a phenethyl substitution at the tertiary amine in E-ring (replacing n-methyl) produces a compound with DRASTICALLY LOWER addiction potential, while conferring 8-14 fold increases in potency,
And
14-methoxy moities added to traditional morphinons create a molecule which virtually lacks all respiratory depression! (While as well conferring a 500 fold increase in potency and 100 fold tighter binding affinity to the mu receptor)
I can dig up the references for the above claims if you need to see them
— there is a lot yet to be discovered about the Mu receptor, it seems !!! —
LikeADaVinci
